Extendicare Inc. (TSE:EXE - Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as C$11.35 and last traded at C$11.31, with a volume of 84376 shares trading hands. The stock had previously closed at C$11.12.
Wall Street Analyst Weigh In
Several research firms have recently issued reports on EXE. Cormark raised shares of Extendicare to a "moderate buy" rating in a research report on Wednesday. TD Securities upped their target price on shares of Extendicare from C$9.50 to C$10.50 and gave the stock a "hold" rating in a report on Thursday, November 14th. Royal Bank of Canada upped their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the stock a "sector perform" rating in a report on Thursday, November 28th. Finally, BMO Capital Markets set a C$11.00 target price on shares of Extendicare and gave the stock a "market perform" rating in a report on Thursday, January 30th. Three research analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to data from MarketBeat.com, Extendicare has an average rating of "Hold" and a consensus price target of C$10.25.
Read Our Latest Research Report on Extendicare
Extendicare Stock Down 0.7 %
The stock's fifty day moving average is C$10.53 and its two-hundred day moving average is C$9.60. The company has a current ratio of 0.62, a quick ratio of 0.98 and a debt-to-equity ratio of 283.02. The firm has a market cap of C$955.70 million, a P/E ratio of 14.60 and a beta of 1.26.
Extendicare Dividend Announcement
The business also recently declared a monthly dividend, which will be paid on Monday, March 17th. Stockholders of record on Monday, March 17th will be issued a $0.04 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 4.19%. The ex-dividend date is Friday, February 28th. Extendicare's payout ratio is 61.20%.
About Extendicare
(
Get Free Report)
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC") homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Stories
Before you consider Extendicare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extendicare wasn't on the list.
While Extendicare currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.